4.7 Article

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression

Journal

EMBO MOLECULAR MEDICINE
Volume 6, Issue 6, Pages 821-834

Publisher

WILEY-BLACKWELL
DOI: 10.1002/emmm.201303286

Keywords

IL-18; inflammation; stromal cells; T-ALL

Funding

  1. INSERM
  2. CEA
  3. Universite Paris Diderot
  4. Universite Paris Sud
  5. Institut National du Cancer (INCA, Network)
  6. Canceropole Ile de France
  7. StemPole
  8. Ligue Nationale contre le Cancer (LNCC, equipe labellisee)
  9. Association Laurette Fugain
  10. INCA
  11. LNCC
  12. Societe Francaise d'Hematologie

Ask authors/readers for more resources

Development of novel therapies is critical for T-cell acute leukaemia (T-ALL). Here, we investigated the effect of inhibiting the MAPK/MEK/ERK pathway on T-ALL cell growth. Unexpectedly, MEK inhibitors (MEKi) enhanced growth of 70% of human T-ALL cell samples cultured on stromal cells independently of NOTCH activation and maintained their ability to propagate in vivo. Similar results were obtained when T-ALL cells were cultured with ERK1/2-knockdown stromal cells or with conditioned medium from MEKi-treated stromal cells. Microarray analysis identified interleukin 18 (IL-18) as transcriptionally up-regulated in MEKi-treated MS5 cells. Recombinant IL-18 promoted T-ALL growth in vitro, whereas the loss of function of IL-18 receptor in T-ALL blast cells decreased blast proliferation in vitro and in NSG mice. The NFKB pathway that is downstream to IL-18R was activated by IL-18 in blast cells. IL-18 circulating levels were increased in T-ALL-xenografted mice and also in T-ALL patients in comparison with controls. This study uncovers a novel role of the pro-inflammatory cytokine IL-18 and outlines the microenvironment involvement in human T-ALL development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Germline PAX5 mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia

Nicolas Duployez, Laura A. Jamrog, Vincent Fregona, Camille Hamelle, Laurene Fenwarth, Sophie Lejeune, Nathalie Helevaut, Sandrine Geffroy, Aurelie Caillault, Alice Marceau-Renaut, Stephanie Poulain, Catherine Roche-Lestienne, Laetitia Largeaud, Nais Prade, Stephanie Dufrechou, Sylvie Hebrard, Celine Berthon, Brigitte Nelken, Jose Fernandes, Celine Villenet, Martin Figeac, Bastien Gerby, Eric Delabesse, Claude Preudhomme, Cyril Broccardo

BLOOD (2021)

Article Hematology

The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma

Baptiste Eluard, Stephanie Nuan-Aliman, Nathalie Faumont, Davi Collares, Didier Bordereaux, Aurelie Montagne, Isabelle Martins, Nicolas Cagnard, Martial Caly, Oussama Taoui, Leonardo Lordello, Jacqueline Lehmann-Che, Bruno Tesson, Jose-Angel Martinez-Climent, Christiane Copie-Bergman, Corinne Haioun, Herve Tilly, Benjamin Bonsang, Anne Vincent-Salomon, Jean-Philippe Jais, Fabrice Jardin, Karen Leroy, Maria Chiara Maiuri, Guido Kroemer, Thierry Jo Molina, Jean Feuillard, Veronique Baud

Summary: RelB activation is frequently observed in DLBCL and defines a new subset of patients with distinct gene expression profile and mutational pattern. RelB positivity is associated with poor prognosis after immunochemotherapy, and it confers resistance to doxorubicin-induced apoptosis in DLBCL cells.

BLOOD (2022)

Article Biochemical Research Methods

Ultrahigh-Resolution NMR with Water Signal Suppression for a Deeper Understanding of the Action of Antimetabolic Drugs on Diffuse Large B-Cell Lymphoma

Gildas Bertho, Leonardo Lordello, Xi Chen, Covadonga Lucas-Torres, Imed Eddine Oumezziane, Cedric Caradeuc, Mathieu Baudin, Stephanie Nuan-Aliman, Catherine Thieblemont, Veronique Baud, Nicolas Giraud

Summary: Ultrahigh-resolution NMR has attracted considerable attention in complex sample analysis. Pure shift methods have shown to be suitable for deciphering metabolite mixtures.

JOURNAL OF PROTEOME RESEARCH (2022)

Article Biochemistry & Molecular Biology

Differential Expression of Genes Involved in Metabolism and Immune Response in Diffuse and Intestinal Gastric Cancers, a Pilot Ptudy

Martine Perrot-Applanat, Cynthia Pimpie, Sophie Vacher, Ivan Bieche, Marc Pocard, Veronique Baud

Summary: This study found that the expression of IDO1 and PD1 is significantly increased in intestinal gastric cancer, while the expression of IDO1-TDO2 and PD-L1 is lower in diffuse gastric cancer, with less infiltration of immune cells. Tryptophan metabolism and AhR activation play an important role in immune regulation in gastric cancer.

BIOMEDICINES (2022)

Article Hematology

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11

Marina Lafage-Pochitaloff, Bastien Gerby, Veronique Baccini, Laetitia Largeaud, Vincent Fregona, Nais Prade, Pierre-Yves Juvin, Laura Jamrog, Pierre Bories, Sylvie Hebrard, Stephanie Lagarde, Veronique Mansat-De Mas, Oliver M. Dovey, Kosuke Yusa, George S. Vassiliou, Joop H. Jansen, Tobias Tekath, David Rombaut, Genevieve Ameye, Carole Barin, Audrey Bidet, John Boudjarane, Marie-Agnes Collonge-Rame, Carine Gervais, Antoine Ittel, Christine Lefebvre, Isabelle Luquet, Lucienne Michaux, Nathalie Nadal, Helene A. Poirel, Isabelle Radford-Weiss, Benedicte Ribourtout, Steven Richebourg, Stephanie Struski, Christine Terre, Isabelle Tigaud, Dominique Penther, Virginie Eclache, Michaela Fontenay, Cyril Broccardo, Eric Delabesse

Summary: This study investigated 113 cases of MDS and MDS/MPN with del(11q), revealing clinical features such as female predominance, similar survival prognosis to other MDS, low monocyte count, and abnormal megakaryopoiesis. The study also identified the common deleted region at 11q23.2, which is located between CADM1 and NXPE2 genes.

BLOOD ADVANCES (2022)

Article Biology

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2low resting monocytes

Elodie Pronier, Aygun Imanci, Dorothee Selimoglu-Buet, Bouchra Badaoui, Raphael Itzykson, Thierry Roger, Chloe Jego, Audrey Naimo, Maela Francillette, Marie Breckler, Orianne Wagner-Ballon, Maria E. Figueroa, Marine Aglave, Daniel Gautheret, Francoise Porteu, Olivier A. Bernard, William Vainchenker, Francois Delhommeau, Eric Solary, Nathalie M. Droin

Summary: This study demonstrates that TET2 downregulation promotes the production of MIF, a chemokine associated with clonal TET2 downregulation in myeloid cells. Targeting MIF could be a potential therapeutic strategy for conditions associated with TET2 mutations.

COMMUNICATIONS BIOLOGY (2022)

Letter Oncology

REDD1 is a gatekeeper of murine hematopoietic stem cell functions during stress responses

Vilma Barroca, Elia Henry, Nathalie Dechamps, Laurent Renou, Paul Chaintreuil, Rohan Kulkarni, Saiyirami Devanand, Arnaud Jacquel, Guillaume Robert, Patrick Auberger, Francoise Pflumio, Marie-Laure Arcangeli

LEUKEMIA (2022)

Article Cell & Tissue Engineering

Transcriptional profiling of β-2M-SPα-6+THY1+ spermatogonial stem cells in human spermatogenesis

Maelle Givelet, Virginie Firlej, Bruno Lassalle, Anne Sophie Gille, Clementine Lapoujade, Isabelle Holtzman, Amandine Jarysta, Farahd Haghighirad, Florent Dumont, Sebastien Jacques, Franck Letourneur, Francoise Pflumio, Isabelle Allemand, Catherine Patrat, Nicolas Thiounn, Jean Philippe Wolf, Lydia Riou, Virginie Barraud-Lange, Pierre Fouchet

Summary: Researchers have established an exhaustive transcriptome of human spermatogenesis by analyzing the characteristics of human germ cells, revealing the molecular networks and key transcriptional regulators involved in the regulation of human spermatogonial stem cells.

STEM CELL REPORTS (2022)

Article Immunology

Monoallelic Heb/Tcf12 Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia

Diogo F. T. Veiga, Mathieu Tremblay, Bastien Gerby, Sabine Herblot, Andre Haman, Patrick Gendron, Sebastien Lemieux, Juan Carlos Zuniga-Pflucker, Josee Hebert, Joseph Paul Cohen, Trang Hoang

Summary: Early T-cell development is controlled by E proteins, NOTCH1 and pre-TCR signaling. Perturbations of these pathways are implicated in leukemogenesis. This study investigates the individual roles of HEB, E2A, NOTCH1, and Tcf12 in T-ALL using gene-deficient mice. The findings suggest that HEB and E2A restrain cell proliferation, Tcf12 gene dosage is essential for the clonal expansion of pre-leukemic stem cells, and HEB acts as a tumor suppressor in T-ALL.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

NF-κB signaling controls H3K9me3 levels at intronic LINE-1 and hematopoietic stem cell genes in cis

Yanis Pelinski, Donia Hidaoui, Anne Stolz, Francois Hermetet, Rabie Chelbi, M'boyba Khadija Diop, Amir M. Chioukh, Francoise Porteu, Emilie Elvira-Matelot

Summary: Ionizing radiation leads to loss of HSC function, associated with loss of H3K9me3 at intronic LINE-1 of HSC genes. The TNF-alpha/NF-kappa B/H3K9me3/LINE-1 axis maintains HSC gene expression and function independently of DNA damage.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Chemistry, Analytical

Absolute Metabolite Quantification Using Pure Shift NMR: Toward Quantitative Metabolic Profiling of Aqueous Biological Samples

X. Chen, C. Caradeuc, A. Montagne, V. Baud, G. Bertho, C. Lucas-Torres, N. Giraud

Summary: Accurate quantification of metabolites by NMR is crucial for understanding metabolic pathways and addressing diseases. A new analytical protocol using pure shift library of calibration reference spectra has been developed to determine metabolite concentrations. This method, validated through model mixtures, provides quantitative and high-resolution vision of metabolic processes in a time compatible with metabolomics studies. Furthermore, it has been successfully applied to determine absolute metabolite concentrations in a lymphoma extracellular medium.

ANALYTICAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia

Awatef Allouch, Laurent Voisin, Yanyan Zhang, Syed Qasim Raza, Yann Lecluse, Julien Calvo, Dorothee Selimoglu-Buet, Stephane de Botton, Fawzia Louache, Francoise Pflumio, Eric Solary, Jean-Luc Perfettini

Summary: Targeting the reprogramming and phagocytic capacities of tumor-associated macrophages (TAMs) offers a therapeutic opportunity for cancer treatment. In this study, the authors demonstrate that overexpressing CDKN1A/p21 in engineered macrophages reduces leukemia tumor burden and extends survival in mouse models of T-ALL.

NATURE COMMUNICATIONS (2022)

Article Oncology

From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis

Marie-Berengere Troadec, Francoise Porteu, Marie -Laure Arcangeli, Adlen Foudi, Dominique Bluteau, Paulo De Sepulveda, Christel Guillouf, Nathalie M. Mazure, Fabienne Meggetto, Philippe Brunet De La Grange, Cyril Broccardo

Summary: This article summarizes the presentations from the 2021 scientific meeting of the Club Hematopoiesis and Oncogenesis. The meeting focused on hematopoiesis and oncogenic mechanisms, covering topics such as expansion of hematopoietic stem cells, the role of stem cell niches, the intersection of hematology and immunology, the importance of metabolism in hematopoiesis, solid tumors and oncogenesis, the noncoding genome, inflammation in monocyte differentiation and leukemia, as well as recent advances in myeloid malignancies, lymphoid leukemia, and lymphoma.

BULLETIN DU CANCER (2023)

Article Chemistry, Physical

A Toolbox for Glutamine Use in Dissolution Dynamic Nuclear Polarization: from Enzymatic Reaction Monitoring to the Study of Cellular Metabolic Pathways and Imaging.

Karen Dos Santos, Gildas Bertho, Cedric Caradeuc, Veronique Baud, Aurelie Montagne, Daniel Abergel, Nicolas Giraud, Mathieu Baudin

Summary: Researchers used a new technique to study the metabolic changes of glutamine in cancer cells. They used [5-C-13] glutamine and [1,4-C-13] asparagine as molecular probes, studied the actions of several enzymes, and explored the use of hyperpolarized substrates to probe metabolic pathways. They also proposed a highly concentrated sample formulation for fast imaging applications.

CHEMPHYSCHEM (2023)

Article Biology

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

Maria Eugenia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, Robin Droit, Wan Ching Lim, Antonin Marchais, Jerome Salmon, Sarah Cherkaoui, Raphael J. Morscher, Anouchka Laurent, Sebastien Malinge, Thomas Mercher, Severine Tabone-Eglinger, Isabelle Goddard, Francoise Pflumio, Julien Calvo, Francoise Redini, Natacha Entz-Werle, Aroa Soriano, Alberto Villanueva, Stefano Cairo, Pascal Chastagner, Massimo Moro, Cormac Owens, Michela Casanova, Raquel Hladun-Alvaro, Pablo Berlanga, Estelle Daudigeos-Dubus, Philippe Dessen, Laurence Zitvogel, Ludovic Lacroix, Gaelle Pierron, Olivier Delattre, Gudrun Schleiermacher, Didier Surdez, Birgit Geoerger

Summary: This study developed patient-derived-xenograft (PDX) models for pediatric patients with recurrent and refractory cancers, providing essential support for research and treatment development in advanced pediatric malignancies.

COMMUNICATIONS BIOLOGY (2023)

No Data Available